Who are Novo Nordisk A/S's main suppliers?

Novo Nordisk A/S (NONOF) key suppliers include: EXECUTIVE-MANAGEMENT. View the full supplier network at chainsifter.com/chain/NONOF.

Who are Novo Nordisk A/S's major customers?

Novo Nordisk A/S (NONOF) key customers include: HIKMA-PHARMACEUTICALS-PLC, Teva Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, ALVOGEN-INC, APOTEX-INC and 6 more. View the full customer network at chainsifter.com/chain/NONOF.

What sector is Novo Nordisk A/S in?

Novo Nordisk A/S (NONOF) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NONOF Supply Chain: Novo Nordisk A/S Suppliers & Customers

1Suppliers

11Customers

1Debt Items

20Related Chains

Novo Nordisk A/S Suppliers

Ticker	Name	Confidence	Evidence
EXECUTIVE-MANAGEMENT	EXECUTIVE-MANAGEMENT	62%	s areas, while long-term risks are assessed as part of our company-wide strategic risk identification process. When identifying material climate risks, the same time horizons have been applied as for…

Novo Nordisk A/S Customers

Ticker	Name	Confidence	Evidence
HIKMA-PHARMACEUTICALS-PLC	HIKMA-PHARMACEUTICALS-PLC	90%	Hikma Pharmaceuticals PLC launched its generic liraglutide product in December 2024
TEVA	Teva Pharmaceutical Industries Limited	90%	Teva launched an authorised generic 7 Novo Nordisk Form 20-F 2025 ITEM 4 INFORMATION ON THE COMPANY version of Victoza ® in June 2024
TEVA	Teva Pharmaceutical Industries Limited	90%	Reciprocal relationship from TEVA graph: Reciprocal relationship from NONOF graph: Teva launched an authorised generic 7 Novo Nordisk Form 20-F 2025 ITEM 4 INFORMATION ON THE COMPANY version of Victo…
ALVOGEN-INC	ALVOGEN-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
APOTEX-INC	APOTEX-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
MYLAN-PHARMACEUTICALS-INC	MYLAN-PHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
RDY	Dr. Reddy's Laboratories Limited	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
RDY	Dr. Reddy's Laboratories Limited	80%	Reciprocal relationship from RDY graph: Reciprocal relationship from NONOF graph: Reciprocal relationship from RDY graph: Reciprocal relationship from NONOF graph: Novo Nordisk has entered into settl…
RIO-BIOPHARMACEUTICALS-INC	RIO-BIOPHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED	SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
ZYDUS-PHARMACEUTICALS-INC	ZYDUS-PHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…

Novo Nordisk A/S Debt Obligations

Instrument	Description	Confidence	Evidence
NONOF-DEBT	Debt stack $22.8B	90%	Market cache reports total debt of $22.8B.

Novo Nordisk A/S Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Novo Nordisk A/S.

Novo Nordisk A/S Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Novo Nordisk A/S.

Novo Nordisk A/S Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ASND	Ascendis Pharma A/S	100.00	2
HIMS	Hims & Hers Health, Inc.	100.00	2
IPHA	Innate Pharma S.A.	100.00	2
ALVO	Alvotech	100.00	2
LLY	Eli Lilly and Company	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
CANF	Can-Fite BioPharma Ltd.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
AMRX	Amneal Pharmaceuticals, Inc.	100.00	2
EVAX	Evaxion A/S	100.00	2
TEVJF	Teva Pharmaceutical Industries Limited	100.00	2
SNYNF	Sanofi	100.00	2
TEVA	Teva Pharmaceutical Industries Limited	60.75	1	['customer']
SNY	Sanofi	50.00	2
IMMP	Immutep Limited	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
DERM	Journey Medical Corporation	50.00	2
KRRO	Korro Bio, Inc.	50.00	2
MDGL	Madrigal Pharmaceuticals, Inc.	50.00	2

Novo Nordisk A/S Supply Chain